HCP (HCP) : The highest short term price target forecast on HCP (HCP) is $43 and the lowest target price is $23. A total of 7 equity analysts are currently covering the company. The average price of all the analysts is $31.29 with a standard deviation of $6.26.
HCP (HCP) reported a drop of 2.8% or 456,215 shares in its short interest. The short figure came in at 3.4% of the total floats. The average daily volume of 4,166,962 shares suggests that the days to cover 15,991,131 short positions, as on June 30,2016, will be 4. On June 15,2016, the short interest was 16,447,346 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 12th.
Also, Goldman Sachs upgrades its view on HCP (NYSE:HCP) according to the research report released by the firm to its investors. The shares have now been rated Neutral by the stock experts at the ratings house. The rating by the firm was issued on July 8, 2016.
HCP (NYSE:HCP): On Thursdays trading session , Opening price of the stock was $37.28 with an intraday high of $37.34. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $36.66. However, the stock managed to close at $36.95, a loss of 1.28% for the day. On the previous day, the stock had closed at $37.43. The total traded volume of the day was 2,530,190 shares.
HCP, Inc. (HCP) is a real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital. Its portfolio includes owned portfolio, unconsolidated joint ventures, and developments and redevelopments. Its owned portfolio includes around 1,040 properties under lease and 68 operating properties. It has interests in unconsolidated joint ventures representing around 88 properties in its senior housing, life science and medical office segments. It has assets under development, redevelopment and land held for future development in life science and medical office segments. The properties owned by it in medical office and senior housing segments, which are under development or redevelopment include Pacific Corporate Park, Memorial Hermann, Sky Ridge, Bayfront, Folsom and Deer Park.